Education
About Us
Working with TipRanks
Follow Us
Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ:TELO
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|
| Income Statement | ||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -12.24M | $ -3.94M | $ -854.15K | $ -138.13K |
| EBITDA | $ 48.00K | $ -11.43M | $ 0.00 | $ 0.00 |
| Net Income | $ -16.53M | $ -13.07M | $ -854.15K | $ -138.13K |
| Balance Sheet | ||||
| Cash & Short-Term Investments | $ 1.27M | $ 1.23K | $ 1.42K | $ 0.00 |
| Total Assets | $ 1.32M | $ 4.77M | $ 48.73K | $ 55.00K |
| Total Debt | $ 93.43K | $ 101.00K | $ 581.79K | $ 0.00 |
| Net Debt | $ -1.17M | $ 99.77K | $ 580.37K | $ 0.00 |
| Total Liabilities | $ 680.97K | $ 1.34M | $ 986.01K | $ 138.13K |
| Stockholders' Equity | $ 643.04K | $ 3.44M | $ -937.28K | $ -83.13K |
| Cash Flow | ||||
| Free Cash Flow | $ -5.07M | $ -3.86M | $ -468.66K | $ -119.40K |
| Operating Cash Flow | $ -5.07M | $ -3.86M | $ -468.66K | $ -119.40K |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 6.34M | $ 3.86M | $ 470.08K | $ 119.40K |
Telomir Pharmaceuticals, Inc. Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.